Imogen Fitt

Preliminary data is now available for Signify Research's fourth Digital Pathology Core Market Report! Drop me a note if you'd like to discuss purchasing access or download the brochure here...

“Poor decisions around IT infrastructure can make or break the success of a digital pathology transformation.” – Imogen Fitt, Senior Market Analyst. The digital pathology (DP) market has made tremendous progress over the last four years, with vendors, key opinion leaders and regulatory bodies making significant efforts to educate laboratories on topics like change management, budgetary considerations, and the general DP implementation process.

I hope we all had a lovely July. I'll be busy next month publishing Signify Research's fourth iteration of its Digital Pathology Core Market Report...

Cranfield, UK, 29th July 2024 - Hello, I'm Imogen Fitt from Signify Research. I...

We're now more than halfway through 2024, and there's been a lot happening in digital pathology, so I thought I'd take a moment to review my predictions made earlier this year and offer some insight into where we’re at and how recent developments might impact the future.

Hello everyone, for those who attended, I hope you had a great time at ECDP!

Here is May’s update for the digital pathology community. We start with 3DHISTECH - The Digital Pathology Company announcing the launch of its 'P480 2nd Generation Scanner'.

Hello everyone, this month has been very busy with lots of exciting announcements!

22nd April 2024, USCAP’s annual meeting is one of the largest annual gatherings of pathologists globally, so when landing in Baltimore this year for the 113th event, we were eager to connect with industry leaders old and new to discuss their take on the ‘pulse’ of the conference and what it meant for the future of clinical pathology.

Hello everyone!✨ Fresh off the heels of USCAP in Baltimore I've rounded up the latest news in the DP community.